stock listing
Centogene Gets Nasdaq Non-Compliance Notice
The company has 180 days from the date of the notice to regain compliance with the listing requirement, during which time it will continue to trade on the exchange.
T2 Biosystems Regains Compliance with Nasdaq Listing Requirement
The company had previously been informed that its shares failed to meet the exchange's $1 minimum bid price requirement.
DiaCarta to go Public Through SPAC Merger
The firm would join a number of biopharma and diagnostic companies that have used SPACs during the COVID-19 pandemic to tap the public markets.
AnPac Bio Receives Nasdaq Delisting Determination
The firm plans to appeal the decision, which comes after Nasdaq warned AnPac it did not meet a minimum $1 per share bid price requirement.
T2 Biosystems Regains Nasdaq Listing Requirements
The Massachusetts-based company's minimum market value of listed securities rebounded above $35 million in August, meeting listing requirements.
Jan 25, 2022
AnPac Bio Warned by Nasdaq Over Listing Requirement
Apr 27, 2020
Biocept Files $100M Shelf Registration
Oct 22, 2019
Opko to Offer up to $100M of Common Shares
Mar 15, 2018
Siemens Healthineers IPO Raises €4.2B
Oct 18, 2017
Novacyt Raises €9.7M
Oct 3, 2017
Itus Regains Nasdaq Listing Compliance
Sep 20, 2017
Cell-Based Dx Firm Celcuity Goes Public
Sep 7, 2017
Celcuity Updates Planned IPO
Jun 22, 2017
OpGen Warned by Nasdaq of Non-Compliance
Apr 13, 2017
Interpace Diagnostics Regains Nasdaq Compliance
Jan 25, 2017